How to appeal a Florida Blue pulmonary hypertension denial
ACA §2719 + ERISA §503 · 180-day window · 30-day decision
The framework that applies to your appeal
Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.
Florida Blue-specific note: BCBS licensee for Florida (~5M members). Owned by GuideWell. Prime Therapeutics is the PBM (BCBS-aggregated PBM serving 19 BCBS plans). Florida OIR oversight. Largest ACA Marketplace participant in FL.
What Florida Blue typically denies for pulmonary hypertension
Across Florida Blue's commercial and Medicare books, denials cluster around a small number of patterns. For pulmonary hypertension, expect:
- Marketplace narrow-network denials (BlueCare, myBlue)
- Step therapy via Prime Therapeutics PBM
- Out-of-network reductions citing UCR
- Specialty drug prior auth
Treatments most often denied in this category
These are the pulmonary hypertension treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Winrevair (sotatercept)
- Opsumit (macitentan)
- Letairis (ambrisentan)
- Tracleer (bosentan)
- Adcirca/Alyq (tadalafil)
- Revatio (sildenafil)
How to submit the appeal to Florida Blue
- Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Florida Blue cited in the denial.
- File the appeal through Florida Blue's portal (members: https://www.floridablue.com ; providers: https://providers.floridablue.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In FL, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Frequently asked questions
How long do I have to appeal a Florida Blue pulmonary hypertension denial?
Florida Blue allows 180 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit a Florida Blue appeal?
Members can submit through the Florida Blue member portal at https://www.floridablue.com. Providers should use the provider portal at https://providers.floridablue.com. Faxed and mailed appeals are accepted but take longer.
What denials does Florida Blue most often issue for pulmonary hypertension?
Across Florida Blue's book of business the common patterns include: Marketplace narrow-network denials (BlueCare, myBlue); Step therapy via Prime Therapeutics PBM; Out-of-network reductions citing UCR. For pulmonary hypertension specifically, expect denials tied to the FDA-approved indication, step therapy through cheaper alternatives, and prior authorization documentation gaps.
What if Florida Blue denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Start your Pulmonary hypertension appeal
Upload your Florida Blue denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to ACA §2719 + ERISA §503.
Get started →Contact: hello@denialhelp.com